EGF, epidermal growth factor, 1950

N. diseases: 774; N. variants: 33
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 AlteredExpression group BEFREE Epidermal growth factor-like domain multiple (EGFL7) is overexpressed in less differentiated liver tumors. 30504933 2018
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 Biomarker group BEFREE In summary, our results reveal a novel Hnf4α/miR-122/GALNT10 regulatory pathway that facilitates EGF miR-122 activation and hepatoma growth in HBV-associated hepatocarcinogenesis. 25422324 2015
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 GeneticVariation group BEFREE Epidermal growth factor (EGF) gene single-nucleotide polymorphism (SNP) is associated with an increased risk of hepatic tumors. 24703510 2014
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 Biomarker group BEFREE However, the signaling pathways for EGF-induced motility of hepatoma cells remain undefined. 22701712 2012
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 Biomarker group BEFREE The tyrphostin AG1478 inhibits proliferation and induces death of liver tumor cells through EGF receptor-dependent and independent mechanisms. 21864510 2011
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 AlteredExpression group BEFREE About 59.09% of HCC liver tumour tissues assayed showed EGF protein expression. 19840254 2010
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 Biomarker group BEFREE Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection. 11916239 2002
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 AlteredExpression group BEFREE To understand the stability of rat EGF receptor mRNAs, we analyzed the expression of EGF receptor mRNAs in the hepatoma cell line, AH66 and liver cells. 9279516 1997
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 AlteredExpression group BEFREE First, transfection experiments of the well-differentiated HepG2 human hepatoma cell line using different expression vectors of the HBV X-region demonstrated that the X-gene product is capable of inducing EGF-R gene overexpression; in addition, by using a stable in vitro expression system for HBV, it was shown that EGF-R gene expression in these cells is greater than in the uninfected parent cells, and that this results in a three-fold increase in 125I-EGF binding. 8396816 1993
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 AlteredExpression group BEFREE Epidermal growth factor (EGF) was found to induce a rapid 2-fold increase in the amount of insulin-like growth factor binding protein-1 (IGFBP-1) mRNA in human hepatoma Hep2G cells, and this was accompanied by a 2-fold increase in IGFBP-1 secretion. 1281991 1992
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 Biomarker group BEFREE Data are presented from a comparative research on expression of epidermal growth factor (EGF) receptors and response to EGF of six independently established cell lines derived from human hepatoma. 2544452 1989
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.100 Biomarker group BEFREE Since this autocrine growth under hormone-free conditions might play a basic role in malignant transformation, we studied the effect on cell replication and the presence of specific membrane receptors of epidermal growth factor (EGF) and insulin on a dedifferentiated human hepatoma cell line, named HA22T/VGH. 3040466 1987